Your Path to Medical Breakthroughs – Safe & High-Value Clinical Trials

A study to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile to help guide physicians to pursue preventative measures which may lead to early detection and treatment of the cancer condition.

A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout

A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Tophaceous Gout

A Randomized, Double-Blind, Single-Dose, 5-Period Crossover Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Subjects With Narcolepsy Type 1

A randomized, double-blind, placebo-controlled,parallel-group, multicenter study of the efficacy andsafety of depemokimab in adult participants withCOPD with Type 2 inflammation

A Phase 2 randomized, double-blind, placebo controlled study to investigate efficacy, safety, immunogenicity, and pharmacokinetics, of GSK3862995B in participants with bronchiectasis

A Phase 3, Double-Blind, Randomized, Placebo-Controlled, ParallelGroup, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, andPharmacokinetics of Masupirdine (SUVN-502) for the Treatment ofAgitation in Participants with Dementia of the Alzheimer's Type